Abvc Biopharma ABVC
NASDAQ ABVC
$1.04 +0.04 (+4.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Abvc Biopharma (ABVC) Preferred Stock Liabilities (2020)

Updated

Abvc Biopharma (ABVC) recorded Preferred Stock Liabilities of $2.15 million in Q3 2020, up 26.9% from the prior quarter.

Analysis

Abvc Biopharma (ABVC) Preferred Stock Liabilities (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn -
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn -
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn -
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn -
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn -
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn -
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn -
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn -
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn -
10 Abvc Biopharma 27.62 Mn 26.32 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 2.15 Mn
Jun 30, 2020 1.70 Mn
API Access

Abvc Biopharma Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=ABVC&period=max&api_key=YOUR_API_KEY